Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis

Table 3 Propensity modeling of high fibrosis score (severe/cirrhosis) patients

Variables	OR	95%CI	P value
Age, years
> 60	Reference
≤ 60	0.999	0.929–1.074	0.987
Sex
Female	Reference
Male	1.177	1.099–1.261	< 0.001
Marital status
Married	Reference
Single	1.082	1.007–1.164	0.032
Unknown	1.057	0.894–1.248	0.523
Ethnicity
Black	Reference
White	0.978	0.854–1.120	0.749
Other	0.887	0.760–1.035	0.129
AFP, ng/ml
≤ 15	Reference
> 15	1.217	1.109–1.334	< 0.001
Unknown	0.959	0.888–1.035	0.286
Tumor size, cm
> 3 cm	Reference
≤ 3 cm	1.165	1.059–1.283	0.002
Unknown	0.975	0.881–1.080	0.635
Number of tumors
Single	Reference
Multiple	1.083	1.002–1.172	0.045
Distance metastasis
No	Reference
Yes	1.091	0.816–1.458	0.559
Unknown	0.908	0.639–1.289	0.587
6th AJCC TNM stage
I	Reference
II	0.92	0.817–1.037	0.174
III	0.901	0.824–0.986	0.025
IV	0.94	0.700–1.261	0.68
Unstaged	1.018	0.862–1.203	0.836
Pathological grade
I	Reference
II	1.038	0.899–1.197	0.619
III	1.097	0.944–1.276	0.226
IV	0.971	0.656–1.438	0.886
Unstaged	1.16	1.003–1.340	0.047

Abbreviation: OR odd ratio, CI confidence interval, AFP serum alpha fetoprotein, AJCC American Joint Committee on cancer

ISSN: 1471-2407